The Daily Biotech Pulse: Avenue Tumbles On Negative Adcom Verdict, Moderna’s Expanded Deal With Rovi, Gilead Takes Equity Stake In Hookipa
Here's a roundup of top developments in the biotech space over the last 24 hours.
Earnings Scheduled For February 16, 2022
Companies Reporting Before The Bell
• Wix.com (NASDAQ:WIX) is projected to report quarterly loss at $0.38 per share on revenue of $331.16 million.
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news flow continued to dominate proceedings, and the week also witnessed presentations at conferences and a couple of initial public offerings.
Alkermes Schizophrenia Med Shows Lower Mean Weight Gain In Early Illness With Schizophrenia
Alkermes plc's (NASDAQ: ALKS) ENLIGHTEN-Early Phase 3b study of Lybalvi (olanzapine & samidorphan)
The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar
Here's a roundup of top developments in the biotech space over the last 24 hours:
Alkermes Announces Results From ENLIGHTEN-Early Phase 3b Study Of LYBALVI In Patients Early In Illness; Study Met Pre-Specified Primary Endpoint, First Secondary Endpoint Did Not Achieve Pre-Specified Significance Level
Alkermes plc (NASDAQ:ALKS) today announced positive topline results from ENLIGHTEN-Early, a phase 3b study that evaluated the effect of LYBALVI® (olanzapine and samidorphan) compared to
Cantor Fitzgerald Upgrades Alkermes to Overweight, Raises Price Target to $32
Cantor Fitzgerald analyst Brandon Folkes upgrades Alkermes (NASDAQ:ALKS) from Neutral to Overweight and raises the price target from $28 to $32.
The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker’s Pancreatic Cancer Drug
Here's a roundup of top developments in the biotech space over the last 24 hours:
